183 related articles for article (PubMed ID: 8927340)
1. [Experimental models in research of the pathomechanism of diabetes mellitus].
Pusztai P; Prechl J; Somogyi A; Szaleczky E; Fehér J
Orv Hetil; 1996 Aug; 137(34):1865-9. PubMed ID: 8927340
[TBL] [Abstract][Full Text] [Related]
2. Animal models utilized in the research of diabetes mellitus--with special reference to insulitis-associated diabetes.
Tarui S; Yamada K; Hanafusa T
Prog Clin Biol Res; 1987; 229():211-23. PubMed ID: 2955426
[TBL] [Abstract][Full Text] [Related]
3. A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes.
Beales PE; Elliott RB; Flohé S; Hill JP; Kolb H; Pozzilli P; Wang GS; Wasmuth H; Scott FW
Diabetologia; 2002 Sep; 45(9):1240-6. PubMed ID: 12242456
[TBL] [Abstract][Full Text] [Related]
4. [Chemically induced (streptozotocin-alloxan) diabetes mellitus in dogs].
Liu S; Wang W; Luo XM; Ye B
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):125-8. PubMed ID: 12212196
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
Reimers JI
Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
[TBL] [Abstract][Full Text] [Related]
6. [Experimental animal models of diabetes mellitus].
Goto Y
Nihon Rinsho; 1991 Feb; 49 Suppl():789-95. PubMed ID: 1851902
[No Abstract] [Full Text] [Related]
7. [Free-radical theory of etiopathogenesis of insulin-dependent diabetes mellitus].
Ciechanowski K; Machoy Z
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):48-50. PubMed ID: 1409043
[No Abstract] [Full Text] [Related]
8. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
9. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
11. Viral infections as potential triggers of type 1 diabetes.
van der Werf N; Kroese FG; Rozing J; Hillebrands JL
Diabetes Metab Res Rev; 2007 Mar; 23(3):169-83. PubMed ID: 17103489
[TBL] [Abstract][Full Text] [Related]
12. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus.
Suresh Y; Das UN
Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):37-52. PubMed ID: 11161584
[TBL] [Abstract][Full Text] [Related]
13. Experimental rodent models of type 2 diabetes: a review.
Islam MS; Loots du T
Methods Find Exp Clin Pharmacol; 2009 May; 31(4):249-61. PubMed ID: 19557203
[TBL] [Abstract][Full Text] [Related]
14. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC
Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297
[TBL] [Abstract][Full Text] [Related]
15. Rodent models of streptozotocin-induced diabetic nephropathy.
Tesch GH; Allen TJ
Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to ICA512/IA-2 in rodent models of IDDM.
Myers MA; Laks MR; Feeney SJ; Mandel TE; Koulmanda M; Bone A; Barley J; Rowley MJ; Mackay IR
J Autoimmun; 1998 Jun; 11(3):265-72. PubMed ID: 9693975
[TBL] [Abstract][Full Text] [Related]
17. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
Ablamunits V; Quintana F; Reshef T; Elias D; Cohen IR
J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
[TBL] [Abstract][Full Text] [Related]
18. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
19. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
20. Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models.
Brøndum E; Nilsson H; Aalkjaer C
Horm Metab Res; 2005 Apr; 37 Suppl 1():56-60. PubMed ID: 15918112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
